TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.

Brian C Shaffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.